Skip to content

A prospective study to compare efficacy and safety of the construction and application of nursing planning module for lymphedema based on information platform

A prospective study to compare efficacy and safety of the construction and application of nursing planning module for lymphedema based on information platform

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070713
Enrollment
Unknown
Registered
2023-04-20
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema

Interventions

control group:The data of lymphedema risk factors were collected by routine telephone follow-up, and the lymphedema related quality of life, lymphedema incidence, time of occurrence, and grade of lymp
intervention group:It was included into the information platform of nursing plan, through which prospective early warning, hierarchical monitoring and intervention were implemented

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Above the age of 18; (2) Patients diagnosed with lymphedema or axillary lymph node dissection after breast cancer surgery; (3) clear consciousness, normal intelligence, certain communication ability; (4) The patient or at least one family member can operate a smart phone; (5) Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: (1) No complete medical records; (2) Active cellulitis, tumor, or other inflammation in the limb affected by lymphedema (combined detumescence treatment may spread infection or worsen symptoms); (3) Moderate to severe heart failure (heart failure can be aggravated by increased central venous volume due to lymphatic reflux); (4) acute deep vein thrombosis (blood clot loss can lead to embolism); (5) severe liver and kidney impairment; (6) suffering from a clearly diagnosed mental illness; (7) Poor compliance, unable to complete the study on schedule.

Design outcomes

Primary

MeasureTime frame
Lymphedema incidence;The upper limb function score of the affected side was improved;

Secondary

MeasureTime frame
Incidence of lymphedema related complications;Lymphedema related quality of life;Clinical target completion rate;

Countries

China

Contacts

Public ContactShi Yanping

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

sypshengxia@163.com+86 18612672376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026